Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype
about
Receptorphin: a conserved peptide derived from the sequence of the opioid receptor, with opioid displacement activity and potent antiproliferative actions in tumor cellsDifferential between protein and mRNA expression of CCR7 and SSTR5 receptors in Crohn's disease patients.Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.Characterization of a human gene related to genes encoding somatostatin receptors.Somatostatin analogs and radiopeptides in cancer therapy.SMS 201-995-induced stimulation of gastric acid secretion via the dorsal vagal complex and inhibition via the hypothalamus in anaesthetized rats.Receptor-mediated tumor targeting with radiopeptides. Part 1. General concepts and methods: applications to somatostatin receptor-expressing tumors.Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae.Analysis of somatostatin receptor subtype mRNA expression in human breast cancer.Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroidcDNA cloning and regional distribution of a novel member of the opioid receptor family.Somatostatin receptor expression and biological functions in endocrine pancreatic cells: review based on a doctoral thesis.The relevance of somatostatin receptors in thyroid neoplasiaSomatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors.Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.Molecular pharmacology of somatostatin-receptor subtypes.Somatostatin receptor 1-5; expression profiles during rat development.Blood Glucose and Insulin Concentrations after Octreotide Administration in Horses With Insulin Dysregulation.Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin.Molecular control of peptide hormone and receptor expression.Somatostatin receptor subtype SSTR2 mediates the inhibition of high-voltage-activated calcium channels by somatostatin and its analogue SMS 201-995.Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells.Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.Potent antagonism by BIM-23056 at the human recombinant somatostatin sst5 receptorCloning and characterization of Pangasianodon hypophthalmus growth hormone gene and its heterologous expression.Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder.Octreoscan in patients with bronchial carcinoid tumours.Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice.Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.Ontogeny of somatostatin binding sites in respiratory nuclei of the human brainstem.Somatostatin receptors bind somatostatin and cortistatinEffects of intracerebroventricular infusion of somatostatin-14 on peripheral glucoregulation in dogs.Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Q24795856-C8A4C6BF-B40E-4C2F-97FD-086E00C104A6Q33633866-D42F8F37-D54E-4137-93A2-288343D9A772Q34409167-DF625D84-F8B9-4051-98C7-FDCEF6808AF2Q34411896-978695CC-A7F0-44EA-8DB5-AC68BC79304AQ34972896-A01774C2-9EDC-4DFE-944E-F926B16CF083Q35872841-99702E02-4DDB-4D2C-8B13-9ACFE6DB7866Q36008285-66B9DD8F-9B7D-4270-8E61-F88056B4E5B9Q36116318-71DDC26A-09B7-4CFB-8256-99EC9BC2962CQ36116487-0F0041D7-8535-41CD-9078-F80107FCDB8BQ36619169-88A9CBF2-0961-485B-A224-CEBEE43299CBQ36747990-B7DA1E09-5A8D-46EA-A352-56598572830DQ36853311-48120936-9640-4579-B6E1-7477FA5C0B59Q36988027-C7F9FB16-2ECD-4A78-8098-7B647A340024Q37363625-21634586-EFCD-444C-BAC4-4923EBFAA62BQ39378866-5EFBA1EA-9BF1-4882-BEDC-5F6768EB7747Q40335177-3AB26A72-C40D-45C1-9654-2B1991355262Q40397426-26EAE6FF-AA5D-43CC-A388-604CF7641DDBQ40505318-82775607-6E91-490D-ACA2-F9A8EF1D2F0AQ40642381-951E27AA-24F4-4CA0-9EC6-DA7B36D924BBQ40642387-4C89DE0B-F1D0-4C5F-9738-8144D4B80E5DQ40995512-4C56F0F5-961A-440E-B914-94C80CDD0FDDQ41001899-E14A8DDF-973A-44DB-B767-AEA0EA5D7227Q41112864-E6E80CAC-1AFE-4C24-86DB-8B7DD86A39C1Q41131960-242F3818-54DF-448E-85AC-40508E3E20C3Q41428116-9A018DDC-4084-4F74-8B33-80A3AA2CC15EQ41455281-047569AF-95CD-4A8C-AE60-FD9A491EF15FQ41818303-CAC8C6E9-21DA-4C6B-A223-CECD3BDA72B4Q42438003-1893CFC2-9CC3-4C47-9B2E-4D0441F9C96CQ42521771-78B95F7F-7964-45FC-AF0F-BCF3675B171AQ42659566-89A0192D-F38F-41AA-AABE-7C04940AF14BQ44112144-C4EB7EB3-81EE-4CAC-BB46-30AA759B900BQ44770894-EB117EFA-D02B-42D1-97BC-543ABEDB2239Q46598895-A1054FD2-9799-4919-8E10-25C0D6A574EEQ46887494-7065763F-17BE-42A5-B994-83D0BF926B63Q48705902-C5328CB2-B5A1-4487-AB6E-DF0A32EC0FA7Q50298256-F35D7964-726E-4F72-AFB5-853A254FEFEDQ51330193-9FC3E00E-9A2E-4811-9C17-AA799C1987B5Q53839704-A17C5C68-217C-4890-8C00-288C8363C245Q54015449-6F08FBFE-6934-445F-B802-368EF5101105Q57144951-F5DEB448-7317-46D9-B08C-171E598A541E
P2860
Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Cloning, functional expression ...... somatostatin receptor subtype
@ast
Cloning, functional expression ...... somatostatin receptor subtype
@en
Cloning, functional expression ...... somatostatin receptor subtype
@nl
type
label
Cloning, functional expression ...... somatostatin receptor subtype
@ast
Cloning, functional expression ...... somatostatin receptor subtype
@en
Cloning, functional expression ...... somatostatin receptor subtype
@nl
prefLabel
Cloning, functional expression ...... somatostatin receptor subtype
@ast
Cloning, functional expression ...... somatostatin receptor subtype
@en
Cloning, functional expression ...... somatostatin receptor subtype
@nl
P2093
P356
P1476
Cloning, functional expression ...... somatostatin receptor subtype
@en
P2093
S Kagimoto
P304
P356
10.1006/BBRC.1993.2122
P407
P577
1993-09-15T00:00:00Z